The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors by Andrew Rodriguez, Carlos Kamiya-Matsuoka, Nazanin K. Majd

Get full text

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study by Siqing Fu, Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon

Get full text

Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial by Andrew J. Brenner, Toral Patel, Ande Bao, William T. Phillips, Joel E. Michalek, Michael Youssef, Jeffrey S. Weinberg, Carlos Kamiya Matsuoka, Marc H. Hedrick, Norman LaFrance, Melissa Moore, John R. Floyd

Get full text

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma by John de Groot, Martina Ott, Jun Wei, Cynthia Kassab, Dexing Fang, Hinda Najem, Barbara O'Brien, Shiao-Pei Weathers, Carlos Kamiya Matsouka, Nazanin K Majd, Rebecca A Harrison, Gregory N Fuller, Jason T Huse, James P Long, Raymond Sawaya, Ganesh Rao, Tobey J MacDonald, Waldemar Priebe, Michael DeCuypere, Amy B Heimberger

Get full text